KCPG
ZBH icon

Kavar Capital Partners Group’s Zimmer Biomet ZBH Stock Holding History

Kavar Capital Partners Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8
Closed – – 409
2015
Q4 		$0 Hold
8
– – ﹤0.01% 532
2015
Q3 		$0 Sell
8
-8
-50% -$802 ﹤0.01% 546
2015
Q2 		$1K Buy
+16
New +$1.77K ﹤0.01% 479

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Kavar Capital Partners Group's ZBH Position: Q1 2016 in Review

Kavar Capital Partners Group sold out of Zimmer Biomet (ZBH) in Q1 2016, closing a stake of 8 shares.

Kavar Capital Partners Group first reported a position in ZBH in Q2 2015 and held it in 3 quarters. The position peaked at $1K in Q2 2015. 746 funds tracked by Wall St. Rank hold ZBH as of Q1 2016.

  • Kavar Capital Partners Group reported no remaining Zimmer Biomet position as of Q1 2016 after selling out during the quarter.
  • Kavar Capital Partners Group sold 8 Zimmer Biomet shares in Q1 2016.
  • Kavar Capital Partners Group first reported a position in Zimmer Biomet in Q2 2015 and held it in 3 quarters.
  • Kavar Capital Partners Group's Zimmer Biomet position peaked at $1K in Q2 2015.
  • 746 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2016.

Based on Kavar Capital Partners Group's 13F filing for Q1 2016, filed 13 May 2019.